Aviva plc (LON:AV – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is GBX 739.75.
A number of brokerages recently weighed in on AV. Berenberg Bank raised their price target on shares of Aviva from GBX 800 to GBX 820 and gave the company a “buy” rating in a research note on Monday, August 17th. Citigroup upped their price target on Aviva from GBX 671 to GBX 721 and gave the company a “neutral” rating in a research report on Wednesday, August 26th. JPMorgan Chase & Co. upped their price objective on shares of Aviva from GBX 715 to GBX 800 and gave the company an “overweight” rating in a report on Thursday, August 13th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a GBX 780 target price on shares of Aviva in a research note on Monday, September 7th.
Aviva Stock Up 0.5%
Insiders Place Their Bets
In other news, insider Pippa Lambert bought 205 shares of the business’s stock in a transaction on Monday, August 17th. The shares were bought at an average price of GBX 729 per share, with a total value of £1,494.45. In the last three months, insiders have purchased 501 shares of company stock valued at $347,603. 0.17% of the stock is currently owned by company insiders.
About Aviva
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products. It also provides insurance cover to individuals, small and medium-sized businesses for risks associated with motor vehicles and medical expenses, as well as property and liability, such as employers' and professional indemnity liabilities.
Featured Stories
- Five stocks we like better than Aviva
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.
